The latest company webinar has come and gone and medicine man has put it up. I watched it live but just went back as something irked me(in a good way). I valued out when watching it but it seems to me important. At about the 2 min mark( start listening at 1 min 30 for context ) RH mentions how others may well be interested in starting a phase 2 trial with PYC’s ADOA drug as it effectively ticks the same boxes for effect. The terminology is complex but essentially it’s about reinvigorating cells and I guess you could think of it as adding fertilizer to your veggies, what works for one works for most others. this was mentioned in the first 2 minutes I am sure it was no coincidence but I have not seen commentary on it, hence my post. Glaucoma was one of the indications it may well help, and that is huge. Talk about a sleeper….. Wake up folks..
PYC Price at posting:
14.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)